SCPH
scPharmaceuticals
SCPH
SCPH
Delisted
SCPH was delisted on the 6th of October, 2025.
59 hedge funds and large institutions have $152M invested in scPharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 21 increasing their positions, 8 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
59
Holders Change
+19
Holders Change %
+47.5%
% of All Funds
0.95%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.05%
New
25
Increased
21
Reduced
8
Closed
6
Calls
$302K
Puts
$693K
Net Calls
-$391K
Net Calls Change
-$440K
Top Buyers
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$13.3M |
| 2 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$12.9M |
| 3 |
PA
Perceptive Advisors
New York
|
+$6.83M |
| 4 |
Millennium Management
New York
|
+$5.74M |
| 5 |
O
OrbiMed
New York
|
+$5.47M |
Top Sellers
| 1 |
5VM
5AM Venture Management
San Francisco,
California
|
-$4.3M |
| 2 |
IC
Ikarian Capital
Dallas,
Texas
|
-$3.13M |
| 3 |
AC
Armistice Capital
New York
|
-$2.47M |
| 4 |
Belvedere Trading
Chicago,
Illinois
|
-$661K |
| 5 |
BFM
Boothbay Fund Management
New York
|
-$192K |
